SHARE

ASCO 2012 - Effect of neoadjuvant abiraterone acetate plus leuprolide acetate on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer: Results of a randomized phase 2 study - Slide Presentation

June 25, 2012

CHICAGO, IL (UroToday.com) - Presented by Mary-Ellen Taplin, MD at the Annual Meeting of the American Society of Clinical Oncology (ASCO)- June 1 - 5, 2012 - McCormick Place - Chicago, IL USA.

View an Editorial Commentary of this Presentation

asco x thumb

Login